Alliance to Protect Insulin Choice Revenue

Non-profit Organizations • • 1-10 Employees

Alliance to Protect Insulin Choice revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Non-profit Organizations industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at Alliance to Protect Insulin Choice

Alison Smart

Founder and Director Alliance to Protect Insulin Choice

Company overview

Headquarters	XX
Website	alliancetoprotectinsulinchoice.org
NAICS	813
Founded	2024
Employees	1-10
Socials

Alliance to Protect Insulin Choice Email Formats

Alliance to Protect Insulin Choice uses 1 email format. The most common is {first name} (e.g., john@alliancetoprotectinsulinchoice.org), used 100% of the time.

Format	Example	Percentage
{first name}	john@alliancetoprotectinsulinchoice.org	100%

About Alliance to Protect Insulin Choice

Everyone who uses insulin as a life-saving therapy should have access to insulins of their choice, that serve them best. APIC is a registered public charity in the USA (EIN 33-2260922) that is comprised of parents, individuals, care givers, and loved ones of those with insulin-dependent diabetes, who volunteer their time to protect insulin options, to ensure that patients have access to the life-saving medications that best serve them. Sixty-two insulins have been discontinued in the past several decades, and none for safety or effectiveness. We don't have many more to lose. The most recent discontinuation notice from Novo Nordisk is for insulin Levemir (detemir). Novo Nordisk has been the sole manufacturer of this insulin for 20 years. We are asking them to slow the discontinuation until a biosimilar (generic) is available.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Funding Data

Alliance to Protect Insulin Choice has never raised funding before.

Frequently asked questions

Alliance to Protect Insulin Choice is located in XX.

Alliance to Protect Insulin Choice generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

Alliance to Protect Insulin Choice has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Alliance to Protect Insulin Choice was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Alliance to Protect Insulin Choice has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Alliance to Protect Insulin Choice

Alison Smart

Founder and Director Alliance to Protect Insulin Choice

4.8

40,000 users